Vestibular Rehabilitation with Intratympanic Drug Therapy in Meniere's Disease

Objective: To evaluate vertigo control and auditory rescue in patients with Meniere's disease treated intratympanic Gentamicin Dexamethasone.
 Study Design: Randomized Control Trial (Clinical Trials. gov Identifier: NCT05355610).Place Duration of Study: ENT Departments CMH Quetta Benazir Bhutto Hospital Rawalpindi Pakistan from Apr 2020 to Mar 2022.
 Methodology: Ninety-three cases unilateral meeting the inclusion criteria were intratym-panic Dexamethasone. Pre post-treatment was assessed on Vestibular Deficit Index. Speech discrimination scores for impact also recorded pre post-treatment.
 Results: In cases, there a statistically significant improvement Index (with p-value 0.001). Although all had reduced speech score, it not (p value=0.08).
 Conclusion: vestibular symptoms can be achieved Gentamicin, at same time, system rescued